tiprankstipranks
Immuneering Corp. Class A (IMRX)
:IMRX
US Market

Immuneering (IMRX) Similar Stocks

Compare
341 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immuneering
$1.80
$64.60M
-35.25%
2 Buy
0 Hold
1 Sell
Moderate Buy
Alnylam Pharma
$283.34
$36.86B
93.39%
17 Buy
5 Hold
0 Sell
Strong Buy
Exelixis
$36.96
$10.34B
20.85
55.42%
10 Buy
7 Hold
0 Sell
Moderate Buy
Incyte
$61.92
$11.98B
228.32
8.67%
6 Buy
11 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$503.20
$129.22B
22.10%
15 Buy
10 Hold
1 Sell
Moderate Buy
Blueprint Medicines
$88.72
$5.65B
1.93%
14 Buy
4 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMRX
Immuneering
1.80
-0.73
-28.85%
ALNY
Alnylam Pharma
283.34
131.27
86.32%
EXEL
Exelixis
36.96
13.26
55.95%
INCY
Incyte
61.92
4.44
7.72%
VRTX
Vertex Pharmaceuticals
503.20
87.17
20.95%
BPMC
Blueprint Medicines
88.72
0.50
0.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis